Targeted therapies in cancer represent a revolutionary approach in cancer treatment, aiming to specifically target cancer cells while minimizing damage to healthy tissues. These therapies work by exploiting unique features or vulnerabilities present in cancer cells, such as specific mutations or overexpressed proteins. Unlike traditional chemotherapy, which can affect all rapidly dividing cells in the body, targeted therapies offer the potential for more precise and effective treatment with fewer side effects. Examples include monoclonal antibodies that block cancer-promoting signals and small molecule inhibitors that interfere with abnormal cellular processes. Research continues to identify new targets and develop innovative targeted therapies, offering hope for more personalized and efficient cancer treatments that improve patient outcomes and quality of life.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States